| Characteristics |
| *RA cases N (%) | Non RA N (%) |
| Gender | Male | 5 (7.6) | 4 (9.8) |
|
| Female | 61 (92.4) | 37 (90.2) |
| Age | 21 - 39 years | 27 (40.9) | 17 (41.5) |
|
| 40 - 60 years | 39 (59.1) | 24 (58.5) |
| Serological RA type | Seropositive RA | 49 (74.2) |
|
|
| Seronegative RA | 17 (25.8) |
|
| Disease activity | Inactive | 15 (27.7) |
|
|
| Low activity | 23 ( 34.8) |
|
|
| Moderate activity | 28 (42.4) |
|
| Anti-rheumatic drugs | HCQ* + MTX* | 24 (36.4) |
|
|
| HCQ+ MTX + oral prednisolone | 12 (18.2) |
|
|
| MTX + oral prednisolone | 10 (15.2) |
|
|
| HCQ only | 9 (13.6) |
|
|
| HCQ + oral prednisolone | 7 (10.6) |
|
|
| Others: AZP*, leflunomide | 2 (3.0) |
|
| Total |
| 66 (100) | 41 (100) |